Arcadia Biosciences (RKDA) Tops Q3 EPS by 11c

Arcadia Biosciences (NASDAQ: RKDA) reported Q3 EPS of ($0.12), $0.11 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $1.88 million versus the consensus estimate of $2 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Gordon Haskett cuts TJX Companies rating to Accumulate
• Daqo New Energy (DQ) Misses Q2 EPS by 67c
• Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance